|
|
|
Insider
Information: |
Onuscheck John Michael |
Relationship: |
SVP & President, Europe |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
116,025 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$8,638,061 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
116,025 |
|
|
Total
Value |
$8,638,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
SVP & President, Europe |
2015-01-01 |
116,025 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
SVP & President, Europe |
|
2014-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
39,044 |
115,060 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Europe |
|
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,875 |
129,530 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Europe |
|
2014-02-24 |
4 |
D |
$13.08 |
$260,331 |
D/D |
(19,903) |
95,157 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Europe |
|
2015-01-01 |
4 |
D |
$13.25 |
$178,941 |
D/D |
(13,505) |
116,025 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Europe |
|
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,297 |
108,374 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Europe |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,962 |
103,119 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, EMEA |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,961 |
72,859 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
|
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,628 |
36,389 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, EMEA |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,238 |
56,135 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, EMEA |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,237 |
74,226 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
|
2011-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,061 |
39,080 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, EMEA |
|
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,061 |
67,528 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, EMEA |
|
2012-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,060 |
53,038 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Europe |
|
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,060 |
78,853 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Europe |
|
2014-02-28 |
4 |
D |
$13.10 |
$61,819 |
D/D |
(4,719) |
103,655 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
|
2009-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
18,302 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
|
2010-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
28,531 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
|
2011-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
42,835 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, EMEA |
|
2012-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
59,331 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, EMEA |
|
2013-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,165 |
75,995 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Europe |
|
2014-02-27 |
4 |
D |
$13.30 |
$53,759 |
D/D |
(4,042) |
99,077 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, EMEA |
|
2013-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,996 |
64,543 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
|
2009-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
13,588 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
|
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
23,656 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, EMEA |
|
2012-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
48,723 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|